Loading organizations...
Neulogy Ventures operates as a regulated venture capital fund, investing strategically in early-stage technology companies. Based in Luxembourg, the firm targets opportunities in genuine innovation, seeking to help entrepreneurs build robust businesses. It provides capital and support to foster startup development within the tech ecosystem, focusing on impactful technology.
Established in 2014, Neulogy Ventures was formed as a Luxembourg-based regulated venture capital fund. This foundation aimed to capitalize on emerging opportunities within the European tech startup landscape. The fund was created to offer a structured platform for strategic capital deployment, addressing the clear need for early-stage investment in innovative companies.
Neulogy Ventures primarily serves founders and early-stage technology companies seeking growth capital and strategic guidance. Its vision centers on cultivating impactful tech ventures that drive market change and economic value. By empowering entrepreneurs, Neulogy Ventures strives to advance technological innovation and ensure its portfolio companies' success.
Key people at Neulogy Ventures.
Neulogy Ventures has 2 tracked investments across 2 companies. The latest tracked deal is $2.5M Seed in VECTARY in October 2016.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 10, 2016 | VECTARY | $2.5M Seed | BlueYard Capital | — |
| May 17, 2016 | SaferPass | $1.1M Seed | LRJ Capital, Neulogy Ventures | — |
Key people at Neulogy Ventures.
Neulogy Ventures is a Luxembourg-regulated venture capital fund founded in 2014, focused on investing in early-stage tech companies primarily in Slovakia and the broader Central and Eastern Europe (CEE) region. With around €65 million in assets under management and a portfolio spanning about 30 companies across 10 countries, Neulogy Ventures targets startups addressing deeptech challenges, especially in climate change, healthcare, and other emerging technology sectors. The firm’s mission is to nurture the next generation of innovators and support the transition toward a knowledge economy by providing hands-on operational support and strategic guidance to entrepreneurs[1][3].
Originating as the first fully regulated seed and VC fund management company based in Slovakia, Neulogy Ventures was established by entrepreneurs with deep experience in investment and startup ecosystems. Key partners include Christian Mandl and Jaroslav Luptak, who bring expertise in entrepreneurship, fundraising, and business development. The fund’s evolution has maintained a strong focus on early-stage investments in SMEs operating in Slovakia, with a commitment to professional, transparent, and collaborative partnerships with founders and investors alike[1][3][4].
Neulogy Ventures rides the growing trend of deeptech and climate-tech innovation in the CEE region, a market gaining momentum due to increasing global focus on sustainability and healthcare technology. The timing is favorable as the region’s startup ecosystem matures, supported by rising entrepreneurial talent and improving regulatory frameworks. Neulogy’s influence extends beyond capital, fostering a knowledge economy by enabling startups to scale internationally and addressing global challenges through technology-driven solutions[1][3].
Looking ahead, Neulogy Ventures is poised to deepen its impact by continuing to back mission-driven entrepreneurs who push technological frontiers, particularly in climate change and healthcare. Trends such as AI integration, sustainability-focused innovation, and digital transformation in traditional industries will likely shape their investment focus. As the CEE startup ecosystem grows, Neulogy’s role as a leading deeptech investor and ecosystem builder is expected to strengthen, potentially expanding its geographic reach and portfolio diversity while maintaining its hands-on, founder-centric approach[1][3][4].
